Answers are grounded in this paper and cite their sources.
In vitro analysis demonstrates serotonin derivatives' effect on BACE 1 activity, suggesting utility in Alzheimer's disease research.
All serotonin derivatives described here (1–9) inhibited BACE 1 in a dose dependent manner. The 50% Inhibition Concentration (IC50 ) of N -cinnamoyl serotonin (1) was 86.7 ± 4.0 M. The peptide conjugation of serotonin derivatives influenced the BACE 1 inhibitory activity. Among serotonin derivatives (1–8), introduction of substituents, such as hydroxyl and methoxy groups at the 4 -position decreased the inhibitory activity (N - p -coumaroyl serotonin (2), N - p -methoxy cinnamoyl serotonin (3)). With a hydroxylgroup at the 4 -position, and the meta -hydroxy function being substituted by a hydroxyl group or methoxy group ( N caffeoyl serotonin (4), N -feruloyl serotonin (5)), inhibitory activity was weakened, (IC50 > 400 M). BACE 1 inhibitory activity was effected by the substituents of the cinnamic acid moiety. This is the first report on Structure-Activity-Relationships (SAR) for the BACE 1-inhibiting activity of serotonin derivatives. These serotonin derivatives, which have anti-oxidative effects as well are expected to be useful in the study of the mechanisms of Alzheimer's disease.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: